These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 739968)

  • 21. [Drug resistance of bacteria and countermeasures--current status of resistance. 5. Anaerobic bacteria].
    Watanabe K; Ueno K
    Nihon Rinsho; 1986 Apr; 44(4):982-6. PubMed ID: 3761600
    [No Abstract]   [Full Text] [Related]  

  • 22. [Appearance in France of penicillinase-producing Neisseria gonorrhoeae with high-level resistance to tetracyclines].
    Casin I; Perenet F; Issoire C; Meouchy R; Riou JY; Morel P; Perol Y
    Presse Med; 1990 May; 19(20):968. PubMed ID: 2141139
    [No Abstract]   [Full Text] [Related]  

  • 23. Antimycoplasmal activities of new quinolones, tetracyclines, and macrolides against Mycoplasma pneumoniae.
    Arai S; Gohara Y; Kuwano K; Kawashima T
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1322-4. PubMed ID: 1416832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Field study on the development of resistance of Chlamydia psittaci to tetracyclines].
    Henning K; Krauss H
    Berl Munch Tierarztl Wochenschr; 1986 Nov; 99(11):381-2. PubMed ID: 3814070
    [No Abstract]   [Full Text] [Related]  

  • 25. Tetracycline analogs whose primary target is not the bacterial ribosome.
    Chopra I
    Antimicrob Agents Chemother; 1994 Apr; 38(4):637-40. PubMed ID: 8031024
    [No Abstract]   [Full Text] [Related]  

  • 26. Transport of tetracyclines into Escherichia coli requires a carboxamide group at the C2 position of the molecule.
    Chopra I
    J Antimicrob Chemother; 1986 Dec; 18(6):661-6. PubMed ID: 3546242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent developments in tetracycline antibiotics.
    Sum PE; Sum FW; Projan SJ
    Curr Pharm Des; 1998 Apr; 4(2):119-32. PubMed ID: 10197036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibacterial activity of a new thiatetracycline.
    Bakhtiar M; Selwyn S
    J Antimicrob Chemother; 1983 Mar; 11(3):291. PubMed ID: 6841310
    [No Abstract]   [Full Text] [Related]  

  • 29. [New paths to highly effective tetracyclines].
    Holzgrabe U
    Pharm Unserer Zeit; 2005; 34(4):258-9. PubMed ID: 16041951
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro activity of five tetracyclines and some other antimicrobial agents against four porcine respiratory tract pathogens.
    Pijpers A; Van Klingeren B; Schoevers EJ; Verheijden JH; Van Miert AS
    J Vet Pharmacol Ther; 1989 Sep; 12(3):267-76. PubMed ID: 2810475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetracyclines: new look at old antibiotic. I. Clinical pharmacology, mechanism of action, and untoward effects.
    Siegel D
    N Y State J Med; 1978 May; 78(6):950-6. PubMed ID: 274633
    [No Abstract]   [Full Text] [Related]  

  • 32. Omadacycline invitro activity against a molecularly characterized collection of clinical isolates with known acquired tetracycline resistance mechanisms.
    Mendes RE; Huband MD; Streit JM; Castanheira M; Flamm RK
    Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115054. PubMed ID: 32376058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibacterial activity of minocycline alone and associated with other antibiotics (author's transl)].
    Joly BH; Sirot JL; Cluzel MG
    Pathol Biol (Paris); 1976 Apr; 24(4):257-64. PubMed ID: 778758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance of Haemophilus influenzae and its sensitivity of tetracyclines and chloramphenicol (author's transl)].
    Kozamernik-Stojković M; Gashi A
    Plucne Bolesti Tuberk; 1977; 29(3-4):260-4. PubMed ID: 305573
    [No Abstract]   [Full Text] [Related]  

  • 35. Sensitivity in vitro to macrolide antibiotics and tetracyclines of Mycoplasma hyopneumoniae isolated from pneumonic porcine lungs.
    Takahashi K; Kuniyasu C; Yoshida Y; Momotani E
    Natl Inst Anim Health Q (Tokyo); 1978; 18(1):41-2. PubMed ID: 652044
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibiotic susceptibilities of Parachlamydia acanthamoeba in amoebae.
    Maurin M; Bryskier A; Raoult D
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3065-7. PubMed ID: 12183273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, Synthesis, and Biological Evaluation of Hexacyclic Tetracyclines as Potent, Broad Spectrum Antibacterial Agents.
    Sun C; Hunt DK; Chen CL; Deng Y; He M; Clark RB; Fyfe C; Grossman TH; Sutcliffe JA; Xiao XY
    J Med Chem; 2015 Jun; 58(11):4703-12. PubMed ID: 25927406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efflux: how bacteria use pumps to control their microenvironment.
    McIntosh ED
    Handb Exp Pharmacol; 2012; (211):153-66. PubMed ID: 23090601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antimicrobial susceptibility of anaerobic bacteria in a London teaching hospital.
    Phillips I; Warren C; Taylor E; Timewell R; Eykyn S
    J Antimicrob Chemother; 1981 Dec; 8 Suppl D():17-26. PubMed ID: 6917845
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemical modifications in the tetracycline series.
    Valcavi U; Brandt A; Corsi GB; Minoja F; Pascucci G
    J Antibiot (Tokyo); 1981 Jan; 34(1):34-9. PubMed ID: 7251507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.